carboxyamidotriazole (ForwardVue Pharma/University of Alabama at Birmingham)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Namecarboxyamidotriazole (ForwardVue Pharma/University of Alabama at Birmingham)
Drug Alias Namecalcium-channel blocker (ForwardVue Pharma/University of Alabama at Birmingham)CAI-PLGA rod implant
ClassificationSmall molecules
Mechanisms of ActionAngiogenesis inhibitorsVoltage-gated calcium channel blockers
TargetsVoltage-gated calcium channel
Therapy Area/IndicationsDiabetic Retinopathy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Alabama At Birmingham
China Registration ClassN/A

Develop Information

Active CompaniesForwardVue PharmaUniversity Of Alabama At Birmingham
Inactive CompaniesN/A
Active IndicationsDiabetic Retinopathy
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A